Hepatocellular carcinoma in the elderly: clinical characteristics, survival analysis, and prognostic indicators in a cohort of Spanish patients older than 75 years;Carcinoma hepatocelular en el ancioano: Características clínicas análisis de supervivencia y factores pronósticos en una cohorte de pacientes españoles mayores de 75 años

Revista Espanola de Enfermedades Digestivas

Volumn 100, Issue 10, 2008, Pages 625-631

  Fernandez Ruiz M ^a,b   Guerra Vales, J M ^a   Llenas Garcia J ^a   Colina Ruizdelgado, F ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b NONE   (Spain)

Author keywords

Age; Elderly patients; Hepatocellular carcinoma; Prognosis; Survival; Therapy

Indexed keywords

ALPHA FETOPROTEIN;

ADULT; AGED; ARTICLE; ASCITES; BLOOD LEVEL; CANCER RISK; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GROUPS BY AGE; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PALLIATIVE THERAPY; PORTAL VEIN THROMBOSIS; PROGNOSIS; AGE; CHI SQUARE DISTRIBUTION; COMPARATIVE STUDY; EVALUATION; LIVER TUMOR; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; STATISTICAL MODEL; SURVIVAL;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; LIVER NEOPLASMS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 58749101721     PISSN: 11300108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Parkin DM, Bray F, Ferlay J, Pisan P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108.
2. El-Serag HB, Davila JA, Petersen NJ, McGlynn KA. The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann Intern Med 2003; 139: 817-823
3. Pignata S, Gallo C, Daniele B, Elba S, Giorgio A, Capuano G, et al. Characteristics at presentation and outcome of hepatocellular carcinoma (HCC) in the elderly. A study of the Cancer of the Liver Italian Program (CLIP). Crit Rev Oncol Hematol 2006; 59: 243-249
4. Instituto Nacional de Estadística. Indicadores demográficos basicos. Esperanza de vida al nacimiento [consultado 30-10-2007]: Disponible en: http://www.ine.es/inebmenu/mnu-analisis.htm.
5. Calvet X, Bruix J, Bru C, Gines P, Vilana R, Solé M, et al. Natural history of hepatocellular carcinoma in Spain. Five year's experience in 249 cases. J Hepatol 1990; 10: 311-317
6. García-Torres ML, Zaragoza A, Giner R, Primo J, del Olmo JA. Incidencia y factores epidemiológic del carcinoma hepatocelular en Valencia durante el afio 2000. Rev Esp Enferm Dig 2003; 95: 381-384
7. Bernardi D, Errante D, Tirelli U, Salvagno L, Bianco A, Fentiman IS. Insight into the treatment of cancer in older patients: developments in the last decade. Cancer Treat Rev 2006; 32: 277-288
8. Trevisani F, D'Íntino PE, Grazi GL, Caraceni P, Gasbarrini A, Colan-toni A, et al. Clinical and pathologic features of hepatocellular carcinoma in young and older Italian patients. Cancer 1996; 77: 2223-2232
9. Trevisani F, Cantarini MC, Labate AM, De Notariis S, Rapaccini G, Farinati F, et al. Surveillance for hepatocellular carcinoma in elderly Italian patients with cirrhosis: effects on cancer staging and patient survival. Am J Gastroenterol 2004; 99: 1470-1476
10. Poon RTP, Fan ST, Lo CM, Liu CL, Ngan H, Ng IO, et al. Hepatocellular carcinoma in the elderly: results of surgical and nonsurgical management. Am J Gastroenterol 1999; 94: 2460-2466
11. Hanakazi K, Kajikawa S, Shimozawa N, Shimada K, Hiraguri M, Koide N, et al. Hepatic resection for hepatocellular carcinoma in the elderly. J Am Coll Surg 2001; 192: 38-46.
12. Hazama H, Omagari K, Matsuo I, Masuda J, Ohba K, Sakimura K, et al. Clinical features and treatment of hepatocellular carcinoma in eight patients older than eighty years of age. Hepatogastroenterology 2001; 48: 1692-1696
13. Teratani T, Ishikawa T, Shiratori Y, Shiina S, Yoshida H, Imamura M, et al. Hepatocellular carcinoma in elderly patients: beneficial therapeutic efficacy using percutaneous ethanol injection therapy. Cancer 2002; 95: 816-823
14. Dohmen K, Shirahama M, Shigematsu H, Irie K, Ishibashi H. Optimal treatment strategy for elderly patients with hepatocellular carcinoma. J Gastroenterol Hepatol 2004; 19: 859-865
15. Yeh CN, Lee WC, Jeng LB, Chen MF. Hepatic resection for hepatocellular carcinoma in elderly patients. Hepatogastroenterology 2004; 51: 219-223
16. Tsukioka G, Kakizaki S, Sohara N, Sato K, Takagi H, Arai H, et al. Hepatocellular carcinoma in extremely elderly patients: an analysis of clinical characteristics, prognosis and patient survival. World J Gastroenterol 2006; 12: 48-53.
17. Zhou L, Rui JA, Wang SB, Chen SG, Qu Q, Chi TY, et al. Clinicopat-hological features, post-surgical survival and prognostic indicators of elderly patients with hepatocellular carcinoma. Eur J Surg Oncol 2006; 32: 767-772
18. Fujishima T, Ishikawa T, Shiratori Y, Kanda M, Tateishi R, Akamat- su M, et al. Age-related comparison of the profiles of patients with hepatocellular carcinoma. Hepatogastroenterology 2006; 53: 913-918
19. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001; 35: 421-430.
20. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334: 693-699.
21. Llovet JM, Brú C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 1999; 19: 329-338
22. Peng SY, Chen WJ, Lai PL, Jeng YM, Sheu JC, Hsu HC. High α-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and β-catenin mutations. Int J Cancer 2004; 112: 44-50.
23. Hoshida Y, Ikeda K, Kobayashi M, Suzuki Y, Tsubota A, Saitoh S, et al. Chronic liver disease in the extremely elderly of 80 years or more: clinical characteristics, prognosis and patient survival analysis. J Hepatol 1999; 31: 860-866
24. Ng R, de Boer R, Green MD. Undertreatment of elderly patients with non-small-cell lung cancer. Clin Lung Cancer 2005; 7: 168-174
25. Bouchardy C, Rapiti E, Fioretta G, Laissue P, Neyroud-Caspar I, Schafer P, et al. Undertreatment strongly decreases prognosis of breast cancer in elderly women. J Clin Oncol 2003; 21: 3580-3587
26. Petignat P, Fioretta G, Verkooijen HM, Vlastos AT, Rapiti E, Bouchardy C, et al. Poorer survival of elderly patients with ovarian cancer: a population-based study. Surg Oncol 2004; 13: 181-186
27. Yamamoto J, Okada S, Shimada K, Okusaka T, Yamasaki S, Ueno H, et al. Treatment strategy for small hepatocellular carcinoma: comparison of long-term results after percutaneous ethanol injection therapy and surgical resection. Hepatology 2001; 34: 707-713
28. Llovet JM, Bruix J. Systematic review of randomized trials for unre-sectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology 2003; 37: 429-442.
29. Wedding U, Rohrig B, Klippstein A, Pientka L, Hoffken K. Age, severe comorbidity and functional impairment independently contribute to poor survival in cancer patients. J Cancer Res Clin Oncol 2007; 133: 945-950
30. Seve P, Sawyer M, Hanson J, Broussolle C, Dumontet C, Mackey JR. The influence of comorbidities, age, and performance status on the prognosis and treatment of patients with metastatic carcinomas of unknown primary site: a population-based study. Cancer 2006; 106: 2058-2066